| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer
1 company
Beyer Russell P is a Chief Financial Officer at SAB Biotherapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 1 sell.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 26, 2021 | SABS Sab Biotherapeutics, Inc. | Chief Financial Officer | Sell | 278 | $7.90 | $2,196.20 | -100% | -37.7% | -91.9% |